| Year |
Citation |
Score |
| 2022 |
Mujal AM, Combes AJ, Rao AA, Binnewies M, Samad B, Tsui J, Boissonnas A, Pollack JL, Argüello RJ, Meng MV, Porten SP, Ruhland MK, Barry KC, Chan V, Krummel MF. Holistic Characterization of Tumor Monocyte-to-Macrophage Differentiation Integrates Distinct Immune Phenotypes in Kidney Cancer. Cancer Immunology Research. PMID 35181780 DOI: 10.1158/2326-6066.CIR-21-0588 |
0.576 |
|
| 2021 |
Combes AJ, Samad B, Tsui J, Chew NW, Yan P, Reeder GC, Kushnoor D, Shen A, Davidson B, Barczak AJ, Adkisson M, Edwards A, Naser M, Barry KC, Courau T, et al. Discovering dominant tumor immune archetypes in a pan-cancer census. Cell. PMID 34963056 DOI: 10.1016/j.cell.2021.12.004 |
0.569 |
|
| 2021 |
Bickett TE, Knitz M, Darragh LB, Bhatia S, Van Court B, Gadwa J, Bhuvane S, Piper M, Nguyen D, Tu H, Lenz L, Clambey ET, Barry K, Karam SD. FLT3L release by NK cells enhances response to radioimmunotherapy in preclinical models of HNSCC. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34518311 DOI: 10.1158/1078-0432.CCR-21-0971 |
0.304 |
|
| 2020 |
Peterson EE, Barry KC. The Natural Killer-Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy. Frontiers in Immunology. 11: 621254. PMID 33613552 DOI: 10.3389/fimmu.2020.621254 |
0.382 |
|
| 2020 |
Bald T, Krummel MF, Smyth MJ, Barry KC. The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies. Nature Immunology. PMID 32690952 DOI: 10.1038/S41590-020-0728-Z |
0.58 |
|
| 2019 |
Binnewies M, Mujal AM, Pollack JL, Combes AJ, Hardison EA, Barry KC, Tsui J, Ruhland MK, Kersten K, Abushawish MA, Spasic M, Giurintano JP, Chan V, Daud AI, Ha P, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4 T Cell Immunity. Cell. PMID 30955881 DOI: 10.1016/J.Cell.2019.02.005 |
0.541 |
|
| 2019 |
Barry KC, Krummel MF. Abstract PR04: A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-Pr04 |
0.624 |
|
| 2018 |
Barry KC, Hsu J, Broz ML, Cueto FJ, Binnewies M, Combes AJ, Nelson AE, Loo K, Kumar R, Rosenblum MD, Alvarado MD, Wolf DM, Bogunovic D, Bhardwaj N, Daud AI, et al. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nature Medicine. PMID 29942093 DOI: 10.1038/S41591-018-0085-8 |
0.629 |
|
| 2018 |
Mujal A, Barry K, Roberts E, Binnewies M, Ruhland M, Chan V, Krummel MF. Abstract IA05: Imaging- and single cell- based insights into the antitumor immune responses Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-Ia05 |
0.631 |
|
| 2017 |
De Leon JA, Qiu J, Nicolai CJ, Counihan JL, Barry KC, Xu L, Lawrence RE, Castellano BM, Zoncu R, Nomura DK, Luo ZQ, Vance RE. Positive and Negative Regulation of the Master Metabolic Regulator mTORC1 by Two Families of Legionella pneumophila Effectors. Cell Reports. 21: 2031-2038. PMID 29166595 DOI: 10.1016/J.Celrep.2017.10.088 |
0.59 |
|
| 2017 |
Barry KC, Ingolia NT, Vance RE. Global analysis of gene expression reveals mRNA superinduction is required for the inducible immune response to a bacterial pathogen. Elife. 6. PMID 28383283 DOI: 10.7554/Elife.22707 |
0.665 |
|
| 2017 |
Barry KC, Ingolia NT, Vance RE. Author response: Global analysis of gene expression reveals mRNA superinduction is required for the inducible immune response to a bacterial pathogen Elife. DOI: 10.7554/Elife.22707.022 |
0.628 |
|
| 2016 |
Starobinets H, Ye J, Broz M, Barry K, Goldsmith J, Marsh T, Rostker F, Krummel M, Debnath J. Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment. The Journal of Clinical Investigation. PMID 27775547 DOI: 10.1172/Jci85705 |
0.625 |
|
| 2014 |
Grabiner MA, Fu Z, Wu T, Barry KC, Schwarzer C, Machen TE. Pseudomonas aeruginosa quorum-sensing molecule homoserine lactone modulates inflammatory signaling through PERK and eI-F2α. Journal of Immunology (Baltimore, Md. : 1950). 193: 1459-67. PMID 24990083 DOI: 10.4049/Jimmunol.1303437 |
0.361 |
|
| 2013 |
Barry KC, Fontana MF, Portman JL, Dugan AS, Vance RE. IL-1α signaling initiates the inflammatory response to virulent Legionella pneumophila in vivo. Journal of Immunology (Baltimore, Md. : 1950). 190: 6329-39. PMID 23686480 DOI: 10.4049/Jimmunol.1300100 |
0.655 |
|
| 2011 |
Fontana MF, Banga S, Barry KC, Shen X, Tan Y, Luo ZQ, Vance RE. Secreted bacterial effectors that inhibit host protein synthesis are critical for induction of the innate immune response to virulent Legionella pneumophila. Plos Pathogens. 7: e1001289. PMID 21390206 DOI: 10.1371/Journal.Ppat.1001289 |
0.684 |
|
| Show low-probability matches. |